Listed

agilon health, inc.

AGLNYSECIK 1831097HealthcareFiscal year ends Dec 31

Latest reported revenue, Q2 FY2026$1.49bnRevenue, Q2 FY2026, three months to 2026-06-30$1.49bn. XBRL concept us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. 10-Q filed 2026-08-05, accession 0001628280-26-053355.Report this figureThree months to Jun 30, 2026, from the 10-Q filed Aug 5, 2026.

Latest quarter: Q2 FY2026

Three months to Jun 30, 2026, against the same quarter a year earlier.

  • Revenue$1.49bnRevenue, Q2 FY2026, three months to 2026-06-30$1.49bn. XBRL concept us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. 10-Q filed 2026-08-05, accession 0001628280-26-053355.Report this figure+7.2% on a year earlier
  • Gross marginnot reported (Gross profit not reported)No year-earlier figure to compare
  • Operating margin0.8%Operating margin, Q2 FY2026, three months to 2026-06-30. operating income / revenueOperating income: $11.8m. XBRL concept us-gaap:OperatingIncomeLoss. 10-Q filed 2026-08-05, accession 0001628280-26-053355.Revenue: $1.49bn. XBRL concept us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. 10-Q filed 2026-08-05, accession 0001628280-26-053355.Report this figure+9.1 pts on a year earlier
  • Net margin1.2%Net margin, Q2 FY2026, three months to 2026-06-30. net income / revenueNet income: $18.0m. XBRL concept us-gaap:NetIncomeLoss. 10-Q filed 2026-08-05, accession 0001628280-26-053355.Revenue: $1.49bn. XBRL concept us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. 10-Q filed 2026-08-05, accession 0001628280-26-053355.Report this figure+8.7 pts on a year earlier
  • Diluted EPS$1.04Diluted EPS, Q2 FY2026, three months to 2026-06-30$1.04 per share. XBRL concept us-gaap:EarningsPerShareDiluted. 10-Q filed 2026-08-05, accession 0001628280-26-053355.Report this figureSign changed from a year earlier
  • Free cash flow−$60.7mFree cash flow, Q2 FY2026, three months to 2026-06-30. operating cash flow − capital expenditureOperating cash flow: −$57.3m. XBRL concept us-gaap:NetCashProvidedByUsedInOperatingActivities. 10-Q filed 2026-08-05, accession 0001628280-26-053355. Derived: 6-month figure less the 3-month figure.Capital expenditure: $3.4m. XBRL concept us-gaap:PaymentsToAcquirePropertyPlantAndEquipment. 10-Q filed 2026-08-05, accession 0001628280-26-053355. Derived: 6-month figure less the 3-month figure.Report this figure−58.5% on a year earlier

Last eight quarters

Full statements
Revenue$1.49bnOperating margin 0.8%
Diluted EPS$1.04, Q2 FY2026
Free cash flow−$60.7m, Q2 FY2026
agilon health, inc., key figures for the last eight quarters
Line itemUnitQ3 FY20242024-09-30Q4 FY20242024-12-31Q1 FY20252025-03-31Q2 FY20252025-06-30Q3 FY20252025-09-30Q4 FY20252025-12-31Q1 FY20262026-03-31Q2 FY20262026-06-30Shape over the periods
Revenue$m1,451Revenue, Q3 FY2024, three months to 2024-09-30$1.45bn. XBRL concept us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. 10-Q filed 2025-11-04, accession 0001628280-25-048839.Report this figure1,522Revenue, Q4 FY2024, three months to 2024-12-31$1.52bn. XBRL concept us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. 10-K filed 2026-02-25, accession 0001628280-26-011655. Derived: 12-month figure less the 9-month figure.Report this figure1,533Revenue, Q1 FY2025, three months to 2025-03-31$1.53bn. XBRL concept us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. 10-Q filed 2026-05-06, accession 0001628280-26-031270.Report this figure1,395Revenue, Q2 FY2025, three months to 2025-06-30$1.39bn. XBRL concept us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. 10-Q filed 2026-08-05, accession 0001628280-26-053355.Report this figure1,435Revenue, Q3 FY2025, three months to 2025-09-30$1.44bn. XBRL concept us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. 10-Q filed 2025-11-04, accession 0001628280-25-048839.Report this figure1,569Revenue, Q4 FY2025, three months to 2025-12-31$1.57bn. XBRL concept us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. 10-K filed 2026-02-25, accession 0001628280-26-011655. Derived: 12-month figure less the 9-month figure.Report this figure1,420Revenue, Q1 FY2026, three months to 2026-03-31$1.42bn. XBRL concept us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. 10-Q filed 2026-05-06, accession 0001628280-26-031270.Report this figure1,495Revenue, Q2 FY2026, three months to 2026-06-30$1.49bn. XBRL concept us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. 10-Q filed 2026-08-05, accession 0001628280-26-053355.Report this figure
Gross margin%not reported (Gross profit not reported)not reported (Gross profit not reported)not reported (Gross profit not reported)not reported (Gross profit not reported)not reported (Gross profit not reported)not reported (Gross profit not reported)not reported (Gross profit not reported)not reported (Gross profit not reported)
Operating margin%(9.2%)Operating margin, Q3 FY2024, three months to 2024-09-30. operating income / revenueOperating income: −$133.5m. XBRL concept us-gaap:OperatingIncomeLoss. 10-Q filed 2025-11-04, accession 0001628280-25-048839.Revenue: $1.45bn. XBRL concept us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. 10-Q filed 2025-11-04, accession 0001628280-25-048839.Report this figure(7.1%)Operating margin, Q4 FY2024, three months to 2024-12-31. operating income / revenueOperating income: −$108.1m. XBRL concept us-gaap:OperatingIncomeLoss. 10-K filed 2026-02-25, accession 0001628280-26-011655. Derived: 12-month figure less the 9-month figure.Revenue: $1.52bn. XBRL concept us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. 10-K filed 2026-02-25, accession 0001628280-26-011655. Derived: 12-month figure less the 9-month figure.Report this figure(1.4%)Operating margin, Q1 FY2025, three months to 2025-03-31. operating income / revenueOperating income: −$22.1m. XBRL concept us-gaap:OperatingIncomeLoss. 10-Q filed 2026-05-06, accession 0001628280-26-031270.Revenue: $1.53bn. XBRL concept us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. 10-Q filed 2026-05-06, accession 0001628280-26-031270.Report this figure(8.3%)Operating margin, Q2 FY2025, three months to 2025-06-30. operating income / revenueOperating income: −$116.0m. XBRL concept us-gaap:OperatingIncomeLoss. 10-Q filed 2026-08-05, accession 0001628280-26-053355.Revenue: $1.39bn. XBRL concept us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. 10-Q filed 2026-08-05, accession 0001628280-26-053355.Report this figure(9.1%)Operating margin, Q3 FY2025, three months to 2025-09-30. operating income / revenueOperating income: −$131.3m. XBRL concept us-gaap:OperatingIncomeLoss. 10-Q filed 2025-11-04, accession 0001628280-25-048839.Revenue: $1.44bn. XBRL concept us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. 10-Q filed 2025-11-04, accession 0001628280-25-048839.Report this figure(12.3%)Operating margin, Q4 FY2025, three months to 2025-12-31. operating income / revenueOperating income: −$193.8m. XBRL concept us-gaap:OperatingIncomeLoss. 10-K filed 2026-02-25, accession 0001628280-26-011655. Derived: 12-month figure less the 9-month figure.Revenue: $1.57bn. XBRL concept us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. 10-K filed 2026-02-25, accession 0001628280-26-011655. Derived: 12-month figure less the 9-month figure.Report this figure0.3%Operating margin, Q1 FY2026, three months to 2026-03-31. operating income / revenueOperating income: $4.0m. XBRL concept us-gaap:OperatingIncomeLoss. 10-Q filed 2026-05-06, accession 0001628280-26-031270.Revenue: $1.42bn. XBRL concept us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. 10-Q filed 2026-05-06, accession 0001628280-26-031270.Report this figure0.8%Operating margin, Q2 FY2026, three months to 2026-06-30. operating income / revenueOperating income: $11.8m. XBRL concept us-gaap:OperatingIncomeLoss. 10-Q filed 2026-08-05, accession 0001628280-26-053355.Revenue: $1.49bn. XBRL concept us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. 10-Q filed 2026-08-05, accession 0001628280-26-053355.Report this figure
Net margin%(8.1%)Net margin, Q3 FY2024, three months to 2024-09-30. net income / revenueNet income: −$117.6m. XBRL concept us-gaap:NetIncomeLoss. 10-Q filed 2025-11-04, accession 0001628280-25-048839.Revenue: $1.45bn. XBRL concept us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. 10-Q filed 2025-11-04, accession 0001628280-25-048839.Report this figure(6.9%)Net margin, Q4 FY2024, three months to 2024-12-31. net income / revenueNet income: −$105.8m. XBRL concept us-gaap:NetIncomeLoss. 10-K filed 2026-02-25, accession 0001628280-26-011655. Derived: 12-month figure less the 9-month figure.Revenue: $1.52bn. XBRL concept us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. 10-K filed 2026-02-25, accession 0001628280-26-011655. Derived: 12-month figure less the 9-month figure.Report this figure0.8%Net margin, Q1 FY2025, three months to 2025-03-31. net income / revenueNet income: $12.1m. XBRL concept us-gaap:NetIncomeLoss. 10-Q filed 2026-05-06, accession 0001628280-26-031270.Revenue: $1.53bn. XBRL concept us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. 10-Q filed 2026-05-06, accession 0001628280-26-031270.Report this figure(7.5%)Net margin, Q2 FY2025, three months to 2025-06-30. net income / revenueNet income: −$104.4m. XBRL concept us-gaap:NetIncomeLoss. 10-Q filed 2026-08-05, accession 0001628280-26-053355.Revenue: $1.39bn. XBRL concept us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. 10-Q filed 2026-08-05, accession 0001628280-26-053355.Report this figure(7.7%)Net margin, Q3 FY2025, three months to 2025-09-30. net income / revenueNet income: −$110.2m. XBRL concept us-gaap:NetIncomeLoss. 10-Q filed 2025-11-04, accession 0001628280-25-048839.Revenue: $1.44bn. XBRL concept us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. 10-Q filed 2025-11-04, accession 0001628280-25-048839.Report this figure(12.0%)Net margin, Q4 FY2025, three months to 2025-12-31. net income / revenueNet income: −$188.9m. XBRL concept us-gaap:NetIncomeLoss. 10-K filed 2026-02-25, accession 0001628280-26-011655. Derived: 12-month figure less the 9-month figure.Revenue: $1.57bn. XBRL concept us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. 10-K filed 2026-02-25, accession 0001628280-26-011655. Derived: 12-month figure less the 9-month figure.Report this figure3.4%Net margin, Q1 FY2026, three months to 2026-03-31. net income / revenueNet income: $48.9m. XBRL concept us-gaap:NetIncomeLoss. 10-Q filed 2026-05-06, accession 0001628280-26-031270.Revenue: $1.42bn. XBRL concept us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. 10-Q filed 2026-05-06, accession 0001628280-26-031270.Report this figure1.2%Net margin, Q2 FY2026, three months to 2026-06-30. net income / revenueNet income: $18.0m. XBRL concept us-gaap:NetIncomeLoss. 10-Q filed 2026-08-05, accession 0001628280-26-053355.Revenue: $1.49bn. XBRL concept us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. 10-Q filed 2026-08-05, accession 0001628280-26-053355.Report this figure
Diluted EPS$ per sharenot reported (Diluted EPS not reported)not reported (Diluted EPS not reported)0.73Diluted EPS, Q1 FY2025, three months to 2025-03-31$0.73 per share. XBRL concept us-gaap:EarningsPerShareDiluted. 10-Q filed 2026-05-06, accession 0001628280-26-031270.Report this figure(6.31)Diluted EPS, Q2 FY2025, three months to 2025-06-30−$6.31 per share. XBRL concept us-gaap:EarningsPerShareDiluted. 10-Q filed 2026-08-05, accession 0001628280-26-053355.Report this figurenot reported (Diluted EPS not reported)not reported (Diluted EPS not reported)2.94Diluted EPS, Q1 FY2026, three months to 2026-03-31$2.94 per share. XBRL concept us-gaap:EarningsPerShareDiluted. 10-Q filed 2026-05-06, accession 0001628280-26-031270.Report this figure1.04Diluted EPS, Q2 FY2026, three months to 2026-06-30$1.04 per share. XBRL concept us-gaap:EarningsPerShareDiluted. 10-Q filed 2026-08-05, accession 0001628280-26-053355.Report this figure
Free cash flow$m(11.2)Free cash flow, Q3 FY2024, three months to 2024-09-30. operating cash flow − capital expenditureOperating cash flow: −$7.7m. XBRL concept us-gaap:NetCashProvidedByUsedInOperatingActivities. 10-Q filed 2025-11-04, accession 0001628280-25-048839. Derived: 9-month figure less the 6-month figure.Capital expenditure: $3.5m. XBRL concept us-gaap:PaymentsToAcquirePropertyPlantAndEquipment. 10-Q filed 2025-11-04, accession 0001628280-25-048839. Derived: 9-month figure less the 6-month figure.Report this figure13.2Free cash flow, Q4 FY2024, three months to 2024-12-31. operating cash flow − capital expenditureOperating cash flow: $16.4m. XBRL concept us-gaap:NetCashProvidedByUsedInOperatingActivities. 10-K filed 2026-02-25, accession 0001628280-26-011655. Derived: 12-month figure less the 9-month figure.Capital expenditure: $3.3m. XBRL concept us-gaap:PaymentsToAcquirePropertyPlantAndEquipment. 10-K filed 2026-02-25, accession 0001628280-26-011655. Derived: 12-month figure less the 9-month figure.Report this figure(35.8)Free cash flow, Q1 FY2025, three months to 2025-03-31. operating cash flow − capital expenditureOperating cash flow: −$32.0m. XBRL concept us-gaap:NetCashProvidedByUsedInOperatingActivities. 10-Q filed 2026-05-06, accession 0001628280-26-031270.Capital expenditure: $3.8m. XBRL concept us-gaap:PaymentsToAcquirePropertyPlantAndEquipment. 10-Q filed 2026-05-06, accession 0001628280-26-031270.Report this figure(38.3)Free cash flow, Q2 FY2025, three months to 2025-06-30. operating cash flow − capital expenditureOperating cash flow: −$35.1m. XBRL concept us-gaap:NetCashProvidedByUsedInOperatingActivities. 10-Q filed 2026-08-05, accession 0001628280-26-053355. Derived: 6-month figure less the 3-month figure.Capital expenditure: $3.3m. XBRL concept us-gaap:PaymentsToAcquirePropertyPlantAndEquipment. 10-Q filed 2026-08-05, accession 0001628280-26-053355. Derived: 6-month figure less the 3-month figure.Report this figure(21.3)Free cash flow, Q3 FY2025, three months to 2025-09-30. operating cash flow − capital expenditureOperating cash flow: −$18.2m. XBRL concept us-gaap:NetCashProvidedByUsedInOperatingActivities. 10-Q filed 2025-11-04, accession 0001628280-25-048839. Derived: 9-month figure less the 6-month figure.Capital expenditure: $3.2m. XBRL concept us-gaap:PaymentsToAcquirePropertyPlantAndEquipment. 10-Q filed 2025-11-04, accession 0001628280-25-048839. Derived: 9-month figure less the 6-month figure.Report this figure(23.5)Free cash flow, Q4 FY2025, three months to 2025-12-31. operating cash flow − capital expenditureOperating cash flow: −$20.5m. XBRL concept us-gaap:NetCashProvidedByUsedInOperatingActivities. 10-K filed 2026-02-25, accession 0001628280-26-011655. Derived: 12-month figure less the 9-month figure.Capital expenditure: $3.0m. XBRL concept us-gaap:PaymentsToAcquirePropertyPlantAndEquipment. 10-K filed 2026-02-25, accession 0001628280-26-011655. Derived: 12-month figure less the 9-month figure.Report this figure20.6Free cash flow, Q1 FY2026, three months to 2026-03-31. operating cash flow − capital expenditureOperating cash flow: $23.7m. XBRL concept us-gaap:NetCashProvidedByUsedInOperatingActivities. 10-Q filed 2026-05-06, accession 0001628280-26-031270.Capital expenditure: $3.1m. XBRL concept us-gaap:PaymentsToAcquirePropertyPlantAndEquipment. 10-Q filed 2026-05-06, accession 0001628280-26-031270.Report this figure(60.7)Free cash flow, Q2 FY2026, three months to 2026-06-30. operating cash flow − capital expenditureOperating cash flow: −$57.3m. XBRL concept us-gaap:NetCashProvidedByUsedInOperatingActivities. 10-Q filed 2026-08-05, accession 0001628280-26-053355. Derived: 6-month figure less the 3-month figure.Capital expenditure: $3.4m. XBRL concept us-gaap:PaymentsToAcquirePropertyPlantAndEquipment. 10-Q filed 2026-08-05, accession 0001628280-26-053355. Derived: 6-month figure less the 3-month figure.Report this figure

Focus or hover a figure to see its XBRL concept, period and filing; each links to that filing. A figure marked d is derived: a quarter computed from year-to-date figures, such as the fourth quarter as the fiscal year less the nine months before it. A ratio reads not reported when any input is missing.

Last five fiscal years

Revenue$5.93bnOperating margin −7.8%
Free cash flow−$119.0m, FY2025
agilon health, inc., key figures for the last five fiscal years
Line itemUnitFY20212021-12-31FY20222022-12-31FY20232023-12-31FY20242024-12-31FY20252025-12-31Shape over the periods
Revenue$m1,521Revenue, FY2021, twelve months to 2021-12-31$1.52bn. XBRL concept us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. 10-K filed 2024-02-27, accession 0001628280-24-007242.Report this figure2,388Revenue, FY2022, twelve months to 2022-12-31$2.39bn. XBRL concept us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. 10-K filed 2025-02-25, accession 0001628280-25-007721.Report this figure4,316Revenue, FY2023, twelve months to 2023-12-31$4.32bn. XBRL concept us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. 10-K filed 2026-02-25, accession 0001628280-26-011655.Report this figure6,061Revenue, FY2024, twelve months to 2024-12-31$6.06bn. XBRL concept us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. 10-K filed 2026-02-25, accession 0001628280-26-011655.Report this figure5,933Revenue, FY2025, twelve months to 2025-12-31$5.93bn. XBRL concept us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. 10-K filed 2026-02-25, accession 0001628280-26-011655.Report this figure
Gross margin%not reported (Gross profit not reported)not reported (Gross profit not reported)not reported (Gross profit not reported)not reported (Gross profit not reported)not reported (Gross profit not reported)
Operating margin%(24.5%)Operating margin, FY2021, twelve months to 2021-12-31. operating income / revenueOperating income: −$372.2m. XBRL concept us-gaap:OperatingIncomeLoss. 10-K filed 2024-02-27, accession 0001628280-24-007242.Revenue: $1.52bn. XBRL concept us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. 10-K filed 2024-02-27, accession 0001628280-24-007242.Report this figure(4.4%)Operating margin, FY2022, twelve months to 2022-12-31. operating income / revenueOperating income: −$105.4m. XBRL concept us-gaap:OperatingIncomeLoss. 10-K filed 2025-02-25, accession 0001628280-25-007721.Revenue: $2.39bn. XBRL concept us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. 10-K filed 2025-02-25, accession 0001628280-25-007721.Report this figure(5.4%)Operating margin, FY2023, twelve months to 2023-12-31. operating income / revenueOperating income: −$232.1m. XBRL concept us-gaap:OperatingIncomeLoss. 10-K filed 2026-02-25, accession 0001628280-26-011655.Revenue: $4.32bn. XBRL concept us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. 10-K filed 2026-02-25, accession 0001628280-26-011655.Report this figure(4.8%)Operating margin, FY2024, twelve months to 2024-12-31. operating income / revenueOperating income: −$292.1m. XBRL concept us-gaap:OperatingIncomeLoss. 10-K filed 2026-02-25, accession 0001628280-26-011655.Revenue: $6.06bn. XBRL concept us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. 10-K filed 2026-02-25, accession 0001628280-26-011655.Report this figure(7.8%)Operating margin, FY2025, twelve months to 2025-12-31. operating income / revenueOperating income: −$463.2m. XBRL concept us-gaap:OperatingIncomeLoss. 10-K filed 2026-02-25, accession 0001628280-26-011655.Revenue: $5.93bn. XBRL concept us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. 10-K filed 2026-02-25, accession 0001628280-26-011655.Report this figure
Net margin%(26.7%)Net margin, FY2021, twelve months to 2021-12-31. net income / revenueNet income: −$406.5m. XBRL concept us-gaap:NetIncomeLoss. 10-K filed 2024-02-27, accession 0001628280-24-007242.Revenue: $1.52bn. XBRL concept us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. 10-K filed 2024-02-27, accession 0001628280-24-007242.Report this figure(4.5%)Net margin, FY2022, twelve months to 2022-12-31. net income / revenueNet income: −$106.6m. XBRL concept us-gaap:NetIncomeLoss. 10-K filed 2025-02-25, accession 0001628280-25-007721.Revenue: $2.39bn. XBRL concept us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. 10-K filed 2025-02-25, accession 0001628280-25-007721.Report this figure(6.1%)Net margin, FY2023, twelve months to 2023-12-31. net income / revenueNet income: −$262.6m. XBRL concept us-gaap:NetIncomeLoss. 10-K filed 2026-02-25, accession 0001628280-26-011655.Revenue: $4.32bn. XBRL concept us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. 10-K filed 2026-02-25, accession 0001628280-26-011655.Report this figure(4.3%)Net margin, FY2024, twelve months to 2024-12-31. net income / revenueNet income: −$260.2m. XBRL concept us-gaap:NetIncomeLoss. 10-K filed 2026-02-25, accession 0001628280-26-011655.Revenue: $6.06bn. XBRL concept us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. 10-K filed 2026-02-25, accession 0001628280-26-011655.Report this figure(6.6%)Net margin, FY2025, twelve months to 2025-12-31. net income / revenueNet income: −$391.3m. XBRL concept us-gaap:NetIncomeLoss. 10-K filed 2026-02-25, accession 0001628280-26-011655.Revenue: $5.93bn. XBRL concept us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. 10-K filed 2026-02-25, accession 0001628280-26-011655.Report this figure
Diluted EPS$ per sharenot reported (Diluted EPS not reported)not reported (Diluted EPS not reported)not reported (Diluted EPS not reported)not reported (Diluted EPS not reported)not reported (Diluted EPS not reported)
Free cash flow$m(155)Free cash flow, FY2021, twelve months to 2021-12-31. operating cash flow − capital expenditureOperating cash flow: −$148.2m. XBRL concept us-gaap:NetCashProvidedByUsedInOperatingActivities. 10-K filed 2024-02-27, accession 0001628280-24-007242.Capital expenditure: $6.6m. XBRL concept us-gaap:PaymentsToAcquirePropertyPlantAndEquipment. 10-K filed 2024-02-27, accession 0001628280-24-007242.Report this figure(146)Free cash flow, FY2022, twelve months to 2022-12-31. operating cash flow − capital expenditureOperating cash flow: −$130.8m. XBRL concept us-gaap:NetCashProvidedByUsedInOperatingActivities. 10-K filed 2025-02-25, accession 0001628280-25-007721.Capital expenditure: $15.4m. XBRL concept us-gaap:PaymentsToAcquirePropertyPlantAndEquipment. 10-K filed 2025-02-25, accession 0001628280-25-007721.Report this figure(172)Free cash flow, FY2023, twelve months to 2023-12-31. operating cash flow − capital expenditureOperating cash flow: −$156.2m. XBRL concept us-gaap:NetCashProvidedByUsedInOperatingActivities. 10-K filed 2026-02-25, accession 0001628280-26-011655.Capital expenditure: $15.8m. XBRL concept us-gaap:PaymentsToAcquirePropertyPlantAndEquipment. 10-K filed 2026-02-25, accession 0001628280-26-011655.Report this figure(71.0)Free cash flow, FY2024, twelve months to 2024-12-31. operating cash flow − capital expenditureOperating cash flow: −$57.8m. XBRL concept us-gaap:NetCashProvidedByUsedInOperatingActivities. 10-K filed 2026-02-25, accession 0001628280-26-011655.Capital expenditure: $13.3m. XBRL concept us-gaap:PaymentsToAcquirePropertyPlantAndEquipment. 10-K filed 2026-02-25, accession 0001628280-26-011655.Report this figure(119)Free cash flow, FY2025, twelve months to 2025-12-31. operating cash flow − capital expenditureOperating cash flow: −$105.8m. XBRL concept us-gaap:NetCashProvidedByUsedInOperatingActivities. 10-K filed 2026-02-25, accession 0001628280-26-011655.Capital expenditure: $13.2m. XBRL concept us-gaap:PaymentsToAcquirePropertyPlantAndEquipment. 10-K filed 2026-02-25, accession 0001628280-26-011655.Report this figure

Focus or hover a figure to see its XBRL concept, period and filing; each links to that filing. A figure marked d is derived: a quarter computed from year-to-date figures, such as the fourth quarter as the fiscal year less the nine months before it. A ratio reads not reported when any input is missing.

Insider purchases and sales

All insider transactions

The last 20 open-market transactions reported on Form 4 (codes P and S). The reported price is the price per share the insider stated on the form: filing data, not a market price.

No open-market purchases or sales by insiders are in coverage from Nov 2024 to Oct 2026.

No open-market purchases or sales by insiders are in coverage for this company.

Funds that report holding it

All funds

From each manager's latest Form 13F, largest reported value first. Reported value is as filed at the quarter end: filing data, not a price. A put or call is an option position, not shares held.

Funds that report holding agilon health, inc.
FundQuarter endedReported valueSharesPut or callChange on the quarter before
Clayton, Dubilier & Rice, LLC2026-06-30$428.7m4,000,000Unchanged
MORGAN STANLEY2026-06-30$215.6m2,011,196Reduced−88,255
North Peak Capital Management, LLC2026-06-30$159.2m1,485,066Reduced−60,471
BlackRock, Inc.2026-06-30$122.9m1,146,520Added+273,356
AQR CAPITAL MANAGEMENT LLC2026-06-30$74.2m692,541Reduced−282,356
GOLDMAN SACHS GROUP INC2026-06-30$73.6m686,792Reduced−375,444
VANGUARD CAPITAL MANAGEMENT LLC2026-06-30$56.3m525,328Reduced−13,208
MARSHALL WACE, LLP2026-06-30$50.2m468,293New+468,293
Durable Capital Partners LP2026-06-30$47.2m440,642New+440,642
D. E. Shaw & Co., Inc.2026-06-30$41.8m390,149Reduced−352,069

Recent filings

All 420 filings

Reports and events: 10-K, 10-Q, 8-K, proxy statements and ownership schedules.

agilon health, inc., recent filings
FiledFormWhat it isAccession number
2026-08-0516:11 ET10-QQuarterly reportPeriod 2026-06-300001628280-26-053355
2026-08-0516:07 ET8-K2.02 Results of operations; 9.01 Financial statements and exhibits0001628280-26-053328
2026-07-2217:51 ET8-K5.02 Departure or appointment of officers or directors; 9.01 Financial statements and exhibits0001628280-26-049080
2026-06-0316:31 ET8-K5.07 Shareholder vote results0001628280-26-040370
2026-05-0616:11 ET10-QQuarterly reportPeriod 2026-03-310001628280-26-031270
2026-05-0616:07 ET8-K2.02 Results of operations; 9.01 Financial statements and exhibits0001628280-26-031254
2026-04-2716:18 ET8-K5.02 Departure or appointment of officers or directors; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits0001628280-26-027512
2026-04-2216:49 ETDEF 14AProxy statementPeriod 2026-06-020001628280-26-026544
2026-03-3017:43 ET8-K3.03 Change to security holders’ rights; 5.03 Amendment to articles or bylaws; 9.01 Financial statements and exhibits0001628280-26-022074
2026-03-1816:06 ET8-K5.07 Shareholder vote results; 8.01 Other events; 9.01 Financial statements and exhibits0001628280-26-019406

Latest annual report

Form 10-K for the fiscal year ended Dec 31, 2025Filed Feb 25, 2026. Its page lists the documents and the extracted sections, such as Business and Risk factors.

Forecast league

Q3 FY2026, the quarter ended 2026-09-30, is open for forecasts until the first results filing for it is accepted by EDGAR. Results are due by [object Promise].Forecast this quarter

About the filer

CIK
1831097
Tickers
AGL
Exchange
NYSE
SIC code
8090 Services-Misc Health & Allied Services, NEC
Sector
Healthcare
Fiscal year ends
Dec 31
Incorporated in
DE
Filer category
Large accelerated filer
Former names
Agilon Health Topco, Inc. (to 2021-02-10)

Source: SEC EDGAR, XBRL company facts, the filing index and Forms 4. Last ingested by Listed: Oct 24, 2026, 15:48 ET. Listed shows no prices and gives no investment advice.